|
09 Aug 2011 |
Tekmira Announces Additional Clinical Trial of TKM-PLK1 with the U.S. National Cancer Institute
|
|
05 Aug 2011 |
MolMed Signs an Agreement With GlaxoSmithKline to Develop a Production Process for a Gene Therapy
|
|
04 Aug 2011 |
Positive Results for Phase IIb Trial of Unique Cell-Based Therapy in Venous Leg Ulcers
|
|
04 Aug 2011 |
Amarantus BioSciences and Generex Biotechnology Collaborate on Cell Therapy for Late Stage Diabetes
|
|
04 Aug 2011 |
Oxford BioMedica Announces Interim Data from Highest (5x) Dose Cohort in ProSavin Phase I/II Study in Parkinson's Disease
|
|
03 Aug 2011 |
Neuralstem Awarded Department of Defense Contract for Brain Cancer Research
|
|
03 Aug 2011 |
Pluristem Announces Effectiveness of the Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension
|
|
02 Aug 2011 |
Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
|
|
01 Aug 2011 |
Alnylam Completes ALN-VSP Phase I Trial in Patients with Liver Cancer
|
